Researched and written by Keith Bishop, Integrative Cancer Educator, Cancer Coach, Clinical Nutritionist, Retired Pharmacist, and Founder of Prevail Over Cancer.
The Big Idea in Plain Language
Binders are sticky on the inside. They grab things. That sounds helpful when the thing is a toxin or a heavy metal. But binders are not smart. They cannot tell the difference between a toxin, your prescription drug, your fish oil, and the iron in your dinner.
If you take a binder at the wrong time, you can block the very things that are keeping you alive and helping you heal.
This blog walks you through what each binder does, what it can take from you, and how to time them safely. We will also look at the rare times binders are truly needed.
Many people on a cancer journey use repurposed antiparasite drugs like fenbendazole and ivermectin. Both have absorption problems already.
Fenbendazole has very poor oral absorption. It needs fat in the meal to be absorbed at all.
Ivermectin absorption increases by about 2.5-fold when taken with food, especially fat.
Now add a binder too close in time. The binder grabs the drug. The drug never reaches your blood. You think the drug is not working. The truth is, your binder ate your dose.
A meta-analysis of studies on activated charcoal showed that it can substantially reduce systemic drug exposure, even when administered after the drug. The charcoal pulls the drug back into the gut from the bloodstream, trapping it.
Section 1: The Nutrient Depletion Problem
Binders are non-selective. They do not pick favorites. When you take a binder with food or supplements, you risk losing the very nutrients you need to heal.
A 2004 rat study published in Bioscience, Biotechnology, and Biochemistry showed that psyllium reduced the absorption of calcium, magnesium, and zinc at higher doses.
A pig study in Toxins (2023) showed that bentonite clay added to the diet reduced zinc digestibility and lowered the digestibility of several amino acids.
For chlorella, research in Algal Research showed that chlorella biomass adsorbed plant polyphenols, including quercetin, catechin, epicatechin, rutin, and xanthohumol. Those are the same compounds we want for cancer defense.
The takeaway is simple. Long-term, daily binder use can quietly drain you.
Section 2: Cancer-Fighting Supplements That Binders Can Steal
If you are spending money and effort on a Prevail Protocol™ supplement stack, you do not want a binder eating your investment.
Polyphenols and fat-soluble compounds are the most at risk because binders love their structure.
Curcumin is fat-soluble and binds to clays and charcoal.
Quercetin is a flavonoid that adsorbs onto the surfaces of chlorella and charcoal.
EGCG from green tea is a polyphenol with the same binding risk.
Resveratrol is fat-soluble and easily caught by clays and charcoal.
Fisetin and berberine share similar risks.
Fish oil and omega-3s are fats and bind directly to clay and charcoal.
Vitamin D3, K2, and A are fat-soluble and follow the same fate.
Good timing makes the difference between a binder being a tool and a binder being a thief. Here are clear rules.
Simple Timing Plan
Time
What to Take
With breakfast (fat included)
Antiparasite drug + fat-soluble supplements
2 hours after breakfast
Water-soluble supplements
4 hours after breakfast
Binder (if used at all)
Lunch
Normal meal, no binder within 2 hours before or after
Dinner
Normal meal, no binder within 2 hours before or after
Bedtime
Binder (if used at all), away from any evening supplements
Key Rules
Wait at least 2 hours after eating, taking drugs, or taking supplements before any binder.
Wait at least 2 to 4 hours after a binder before food, drugs, or supplements.
Do not take a binder every day for long periods. Short, focused use is safer.
Drink extra water with binders to prevent constipation.
During chemo or radiation weeks, skip binders entirely unless your integrative team tells you otherwise.
Section 4: When Binders ARE Truly Needed
Let us be fair. There are times when binders earn their place.
Acute poisoning. Activated charcoal saves lives in the emergency room. It is given within one hour of a toxic ingestion to stop absorption of the poison. This is its real, evidence-based use.
Documented mycotoxin exposure. Bentonite has shown about 95 percent in vitro binding of aflatoxin and is used to lower aflatoxin levels in populations with contaminated food. The World Health Organization has endorsed it for this purpose.
Heavy metal exposure with lab proof. Modified citrus pectin has clinical data for raising urinary excretion of lead, cadmium, and arsenic without depleting essential minerals. This is for confirmed exposure, not guesswork.
Galectin-3 cancer support. MCP at a proper dose and molecular weight has a real role here, but this is a cancer-fighting use, not a "detox" use.
Aside from these clear reasons, the evidence for daily binder use is thin to nonexistent. And the risk of nutrient and drug interference is real.
Prevail. Assess. Don't Guess.™
The Bottom Line
Binders are not free. The price they ask is the cost of your food, supplements, and medicines.
If you are working a full integrative cancer protocol, your supplements and your antiparasite drugs are the tools doing the work. A poorly timed binder can take those tools away from you and leave you wondering why nothing seems to be working.
Used carefully, with clear purpose, and with proper timing, binders may serve a role for a few people. Used daily, in a "more is better" pattern, they may quietly hold you back.
Talk to your integrative practitioner. Test, do not guess.
Neuvonen PJ. Clinical pharmacokinetics of oral activated charcoal in acute intoxications. Clin Pharmacokinet. 1982;7(6):465-489. pubmed.ncbi.nlm.nih.gov/6761032/
Olkkola KT, Neuvonen PJ. Effect of activated charcoal on the absorption of amiodarone. Hum Toxicol. 1984;3(6):483-489. pubmed.ncbi.nlm.nih.gov/1683545/
Skov J, Bladbjerg EM, Sidelmann JJ, et al. The effect of activated charcoal on drug exposure following intravenous administration: A meta-analysis. Basic Clin Pharmacol Toxicol. 2021;129(2):71-82. pubmed.ncbi.nlm.nih.gov/33930237/
Silva-Beltrán NP, Boon SA, Ijaz MK, et al. Activated charcoal. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2024. ncbi.nlm.nih.gov/books/NBK482294
Tomonari M, Shimoda T, Iwasaki H, et al. Effect of activated charcoal on isoniazid absorption in rabbits. Biol Pharm Bull. 2001;24(8):990-993. pubmed.ncbi.nlm.nih.gov/11486611/
Arvela P, Lapinjoki S, Pelkonen O, et al. The bioavailability of two beta-blockers preadsorbed onto charcoal. Methods Find Exp Clin Pharmacol. 1991;13(4):261-266. pubmed.ncbi.nlm.nih.gov/7911863/
Kraljević Pavelić S, Simović Medica J, Gumbarević D, et al. Critical review on zeolite clinoptilolite safety and medical applications in vivo. Front Pharmacol. 2018;9:1350. pubmed.ncbi.nlm.nih.gov/30538633/
Williams LB, Haydel SE. Evaluation of the medicinal use of clay minerals as antibacterial agents. Int Geol Rev. 2010;52(7-8):745-770. pubmed.ncbi.nlm.nih.gov/20640180/
Park J, Kim Y, Hwang S, et al. Effects of a bentonite clay product and a preservative blend on ileal and fecal nutrient digestibility in pigs fed wheat naturally contaminated with deoxynivalenol. Toxins (Basel). 2023;15(12):683. pubmed.ncbi.nlm.nih.gov/38133187/
Wang W, Onnagawa M, Yoshie Y, Suzuki T. Effects of psyllium on rat mineral absorption were reduced after partial degradation by partial acid hydrolysis. Biosci Biotechnol Biochem. 2004;68(8):1737-1740. pubmed.ncbi.nlm.nih.gov/15322358/
Hodek P, Trefil P, Stiborová M. Flavonoids — potent and versatile biologically active compounds interacting with cytochromes P450. Chem Biol Interact. 2002;139(1):1-21. pubmed.ncbi.nlm.nih.gov/11803026/
Suzuki R, Tanaka M, Takanashi M, et al. Evaluation of Chlorella as a decorporation agent to enhance the elimination of radioactive strontium from body. PLoS One. 2016;11(2):e0148080. pubmed.ncbi.nlm.nih.gov/26824701/
Glinsky VV, Raz A. Modified citrus pectin anti-metastatic properties: One bullet, multiple targets. Carbohydr Res. 2009;344(14):1788-1791. pubmed.ncbi.nlm.nih.gov/19061992/
Keskin-Şan S, Esen MS, Şenkardeş İ, et al. Evaluation of in vitro drug-drug interactions of ivermectin and antimalarial compounds. Malar J. 2025;24(1):265. pubmed.ncbi.nlm.nih.gov/40483541/
FDA Disclaimer:Supplement statements have not been evaluated by the Food and Drug Administration. Supplements are not intended to diagnose, treat, cure, or prevent any disease.
Clinical Nutritionist, Cancer Coach, Retired Pharmacist, Author
Keith Bishop founded Prevail Over Cancer and is a passionate advocate for cancer awareness and research. With a background in pharmacy and clinical nutrition I’m dedicated to providing insightful and empowering information to help clients, survivors, and caregivers navigate their journey. From personal experiences and a commitment to holistic health, Keith aims to inspire and support the cancer community through comprehensive and accessible content.
Join over 8,000 subscribers!
Get access to Keith's Prevail Over Cancer Newsletter with news, blogs, and updates!